Search results
Pharma Stock Roundup: J&J to End Hypertension Study & Other Regulatory Updates
Zacks via Yahoo Finance· 9 months agoThis week, J&J JNJ announced its decision to end a late-stage study evaluating its drug Opsumit...
United Therapeutics' Robust Portfolio Fuels Double-Digit Growth
GuruFocus.com via Yahoo Finance· 3 months agoUnited Therapeutics Corp. (NASDAQ:UTHR) is a pharmaceutical company headquartered in Silver Spring,...
Merck (MRK) Posts Positive Results From PAH Drug Study
Zacks via Yahoo Finance· 2 years agoMerck's (MRK) sotatercept meets primary and secondary endpoints in a phase III study in pulmonary...
Eko wins FDA nod for AI to detect sign of heart failure using stethoscope
MedTech Dive via Yahoo Finance· 3 months agoDive Brief: Eko Health received 510(k) clearance for a stethoscope feature that can detect an...
J&J (JNJ) to End Pulmonary Hypertension Study on Opsumit
Zacks via Yahoo Finance· 9 months agoThe decision to end the CTEPH study on J&J's (JNJ) Opsumit (macitentan) was made at the...
How TikTok turned the diabetes drug Ozempic into a diet pill
The Independent via Yahoo News· 2 years agoLET’S UNPACK THAT: There’s been a global shortage of the diabetes treatment Ozempic since it went...
What Is a Congenital Heart Defect?
Health via Yahoo News· 4 months agoWC.GI / Getty Images Medically reviewed by Angela Ryan Lee, MD A congenital heart defect (CHD) occurs when the heart or its blood vessels don't develop...
"You're Next": People Are Sharing The Last Words They Heard Someone Say As They Were Dying, And...
BuzzFeed via Yahoo News· 4 weeks agoRecently, we shared a post where Quora users shared their experiences being present for the final...
Signs and Symptoms of Heart Disease
Health via Yahoo News· 1 year agoMedically reviewed by Rafle Fernandez, MD Heart disease is an umbrella term for a group of health conditions that affect the way the heart functions....
7 F-Rated Biotech Stocks You Shouldn’t Touch With a 10-Foot Pole
InvestorPlace via Yahoo Finance· 10 months agoInvesting in biotech stocks can be challenging. The rewards can be great when your company hits on a...
